BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25122786)

  • 21. Acquisition of Avian-Origin PB1 Facilitates Viral RNA Synthesis by the 2009 Pandemic H1N1 Virus Polymerase.
    Wang F; Liu G; Lu Y; Hlasny M; Liu Q; Zhou Y
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double mutations in the H9N2 avian influenza virus PB2 gene act cooperatively to increase viral host adaptation and replication for human infections.
    Elgendy EM; Arai Y; Kawashita N; Isobe A; Daidoji T; Ibrahim MS; Ono T; Takagi T; Nakaya T; Matsumoto K; Watanabe Y
    J Gen Virol; 2021 Jun; 102(6):. PubMed ID: 34061017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.
    Zhou B; Li Y; Speer SD; Subba A; Lin X; Wentworth DE
    Vaccine; 2012 May; 30(24):3691-702. PubMed ID: 22449422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype.
    Snyder MH; London WT; Maassab HF; Chanock RM; Murphy BR
    Virus Res; 1990 Jan; 15(1):69-83. PubMed ID: 2138396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets.
    Barman S; Krylov PS; Fabrizio TP; Franks J; Turner JC; Seiler P; Wang D; Rehg JE; Erickson GA; Gramer M; Webster RG; Webby RJ
    PLoS Pathog; 2012; 8(7):e1002791. PubMed ID: 22829764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.
    Mori K; Ohniwa RL; Takizawa N; Naito T; Saito M
    J Virol; 2021 May; 95(12):. PubMed ID: 33827947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity and transmissibility of novel reassortant H3N2 influenza viruses with 2009 pandemic H1N1 genes in pigs.
    Ma J; Shen H; Liu Q; Bawa B; Qi W; Duff M; Lang Y; Lee J; Yu H; Bai J; Tong G; Hesse RA; Richt JA; Ma W
    J Virol; 2015 Mar; 89(5):2831-41. PubMed ID: 25540372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice.
    Bi Y; Xie Q; Zhang S; Li Y; Xiao H; Jin T; Zheng W; Li J; Jia X; Sun L; Liu J; Qin C; Gao GF; Liu W
    J Virol; 2015 Jan; 89(1):2-13. PubMed ID: 25320305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the attenuating M and NP gene segments of the avian influenza A/Mallard/78 virus during in vitro production of avian-human reassortant vaccine viruses and after replication in humans and primates.
    Treanor JJ; Tierney EL; London WT; Murphy BR
    Vaccine; 1991 Jul; 9(7):495-501. PubMed ID: 1897305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.
    Wendel I; Rubbenstroth D; Doedt J; Kochs G; Wilhelm J; Staeheli P; Klenk HD; Matrosovich M
    J Virol; 2015 Apr; 89(8):4170-9. PubMed ID: 25631088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.
    Turnbull ML; Wise HM; Nicol MQ; Smith N; Dunfee RL; Beard PM; Jagger BW; Ligertwood Y; Hardisty GR; Xiao H; Benton DJ; Coburn AM; Paulo JA; Gygi SP; McCauley JW; Taubenberger JK; Lycett SJ; Weekes MP; Dutia BM; Digard P
    J Virol; 2016 Oct; 90(20):9263-84. PubMed ID: 27489273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycine at Position 622 in PB1 Contributes to the Virulence of H5N1 Avian Influenza Virus in Mice.
    Feng X; Wang Z; Shi J; Deng G; Kong H; Tao S; Li C; Liu L; Guan Y; Chen H
    J Virol; 2016 Feb; 90(4):1872-9. PubMed ID: 26656683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of HA and PA mutations enhances virulence in a mouse-adapted H6N6 influenza A virus.
    Tan L; Su S; Smith DK; He S; Zheng Y; Shao Z; Ma J; Zhu H; Zhang G
    J Virol; 2014 Dec; 88(24):14116-25. PubMed ID: 25275121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.
    Cox A; Schmierer J; D'Angelo J; Smith A; Levenson D; Treanor J; Kim B; Dewhurst S
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33142846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The R251K Substitution in Viral Protein PB2 Increases Viral Replication and Pathogenicity of Eurasian Avian-like H1N1 Swine Influenza Viruses.
    Cai M; Zhong R; Qin C; Yu Z; Wen X; Xian J; Chen Y; Cai Y; Yi H; Gong L; Zhang G
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly pathogenic avian-derived influenza virus H5N1 with 2009 pandemic H1N1 internal genes demonstrates increased replication and transmission in pigs.
    Abente EJ; Kitikoon P; Lager KM; Gauger PC; Anderson TK; Vincent AL
    J Gen Virol; 2017 Jan; 98(1):18-30. PubMed ID: 28206909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens.
    Wasilenko JL; Lee CW; Sarmento L; Spackman E; Kapczynski DR; Suarez DL; Pantin-Jackwood MJ
    J Virol; 2008 May; 82(9):4544-53. PubMed ID: 18305037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice.
    Zhou B; Li Y; Halpin R; Hine E; Spiro DJ; Wentworth DE
    J Virol; 2011 Jan; 85(1):357-65. PubMed ID: 20962098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.
    Imai M; Watanabe T; Hatta M; Das SC; Ozawa M; Shinya K; Zhong G; Hanson A; Katsura H; Watanabe S; Li C; Kawakami E; Yamada S; Kiso M; Suzuki Y; Maher EA; Neumann G; Kawaoka Y
    Nature; 2012 May; 486(7403):420-8. PubMed ID: 22722205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.